The requirement of tumour necrosis factor-α and interferon-γ for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum
Authors:
- 1 June 1996
- journal article
- Published by Microbiology Society in Microbiology
- Vol. 142 (6) , 1369-1374
Abstract
The present study was conducted to determine the extent to which the cytokines tumour necrosis factor-α (TNF-α) and interferon-γ (IFN-γ) are required to protect against primary or secondary murine tularaemia caused by the live vaccine strain of the facultative intracellular bacteriumFrancisella tularensis. It is shown that non-immune mice treated with neutralizing monoclonal antibodies (mAbs) against TNF-α and IFN-γ are rendered defenceless against otherwise sublethal intravenous inocula of the bacterium. Treatment with either of the anti-cytokine mAbs resulted in even a very small inoculum of 500 c.f.u. of the pathogen multiplying unrestrictedly in the livers, spleens and lungs of non-immune mice to rapidly reach lethal numbers. By contrast,Francisella-immune mice treated with either of the mAbs remained capable of resolving secondary infection with 50-fold larger inocula. However, the need for TNF-α and IFN-γ for controlling secondary tularaemia became critical when challenge inocula exceeded 106c.f.u. Overall, the results imply that different defence mechanisms operate to control primary versus secondary murine tularaemia. Additionally, they show that the need for TNF-α and IFN-γ to combat secondary infection depends on the size of the challenge inoculum.Keywords
This publication has 16 references indexed in Scilit:
- Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytesInfection and Immunity, 1992
- Rapid generation of specific protective immunity to Francisella tularensisInfection and Immunity, 1992
- Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector moleculesInfection and Immunity, 1992
- In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodiesInfection and Immunity, 1992
- Growth of Francisella spp. in rodent macrophagesInfection and Immunity, 1991
- Live vaccine strain of Francisella tularensis: infection and immunity in miceInfection and Immunity, 1991
- Nature of Protective Immunity to Francisella tularensisClinical Infectious Diseases, 1989
- Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities.Journal of Experimental Medicine, 1984
- Immunization against Tularemia: Analysis of the Effectiveness of Live Francisella tularensis Vaccine in Prevention of Laboratory-Acquired TularemiaThe Journal of Infectious Diseases, 1977
- THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCEJournal of Experimental Medicine, 1964